PMID- 19020245
OWN - NLM
STAT- MEDLINE
DCOM- 20090106
LR  - 20131121
IS  - 1546-3141 (Electronic)
IS  - 0361-803X (Linking)
VI  - 191
IP  - 6
DP  - 2008 Dec
TI  - Percutaneous parathyroid ethanol ablation in patients with multiple endocrine 
      neoplasia type 1.
PG  - 1740-4
LID - 10.2214/AJR.07.3431 [doi]
AB  - OBJECTIVE: The objective of our study was to show the efficacy and safety of 
      percutaneous ethanol ablation in managing recurrent primary hyperparathyroidism 
      in patients with multiple endocrine neoplasia type 1 (MEN1) after subtotal 
      parathyroidectomy. CONCLUSION: Ethanol ablation is a viable alternative to 
      reoperation for the management of recurrent primary hyperparathyroidism in 
      patients with MEN1.
FAU - Veldman, Mark W
AU  - Veldman MW
AD  - Department of Radiology, Mayo Clinic, 200 1st St., SW, Rochester, MN 55902, USA.
FAU - Reading, Carl C
AU  - Reading CC
FAU - Farrell, Michael A
AU  - Farrell MA
FAU - Mullan, Brian P
AU  - Mullan BP
FAU - Wermers, Robert A
AU  - Wermers RA
FAU - Grant, Clive S
AU  - Grant CS
FAU - Thompson, Geoff B
AU  - Thompson GB
LA  - eng
PT  - Journal Article
PL  - United States
TA  - AJR Am J Roentgenol
JT  - AJR. American journal of roentgenology
JID - 7708173
RN  - 3K9958V90M (Ethanol)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Ethanol/*administration & dosage
MH  - Humans
MH  - Hyperparathyroidism/*therapy
MH  - Injections, Subcutaneous
MH  - Middle Aged
MH  - Multiple Endocrine Neoplasia Type 1/*therapy
MH  - Neoplasm Recurrence, Local/*therapy
MH  - Parathyroid Neoplasms/*therapy
MH  - Retrospective Studies
MH  - Treatment Outcome
EDAT- 2008/11/21 09:00
MHDA- 2009/01/07 09:00
CRDT- 2008/11/21 09:00
PHST- 2008/11/21 09:00 [pubmed]
PHST- 2009/01/07 09:00 [medline]
PHST- 2008/11/21 09:00 [entrez]
AID - 191/6/1740 [pii]
AID - 10.2214/AJR.07.3431 [doi]
PST - ppublish
SO  - AJR Am J Roentgenol. 2008 Dec;191(6):1740-4. doi: 10.2214/AJR.07.3431.